Showing 2 posts of 2 posts found.
Freeline Therapeutics has announced that it has entered into a definitive agreement with newly established portfolio company Syncona, in which …
The UK is making a £30 million R&D investment into a promising new type of cancer treatment and is to …
MHRA awards Innovation Passports to liver cancer and dementia medicines
Scottish NHS hospital adopts light-activated therapy to reduce surgical infections
Manchester launches nurse-led clinic to improve kidney transplant outcomes
Androlabs and Majorelle expand testosterone therapy into France
Promatix secures Innovate UK funding to advance bispecific ADC programme